vedolizumab
0 sources
vedolizumab
Summary
vedolizumab is a type of chemical entity[1]. vedolizumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (190 views/month).[2]
Key Facts
- vedolizumab's instance of is recorded as type of chemical entity[3].
- vedolizumab's CAS Registry Number is recorded as 943609-66-3[4].
- vedolizumab's ATC code is recorded as L04AA33[5].
- vedolizumab's subclass of is recorded as chemical compound[6].
- vedolizumab's has use is recorded as medication[7].
- vedolizumab's MeSH descriptor ID is recorded as C543529[8].
- vedolizumab's has part is recorded as carbon[9].
- vedolizumab's ChEMBL ID is recorded as CHEMBL1743087[10].
- vedolizumab's Guide to Pharmacology Ligand ID is recorded as 7437[11].
- vedolizumab's Freebase ID is recorded as /m/04q0jnv[12].
- vedolizumab's UNII is recorded as 9RV78Q2002[13].
- vedolizumab's KEGG ID is recorded as D08083[14].
- vedolizumab's DrugBank ID is recorded as DB09033[15].
- vedolizumab's has characteristic is recorded as biopharmaceutical[16].
- vedolizumab's NDF-RT ID is recorded as N0000190759[17].
- vedolizumab's medical condition treated is recorded as graft-versus-host disease[18].
- vedolizumab's medical condition treated is recorded as ulcerative colitis[19].
- vedolizumab's medical condition treated is recorded as colitis[20].
- vedolizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'vedolizumab'}[21].
- vedolizumab's subject has role is recorded as gastrointestinal agent[22].
- vedolizumab's subject has role is recorded as monoclonal antibody[23].
- vedolizumab's UMLS CUI is recorded as C2607726[24].
- vedolizumab's RxNorm CUI is recorded as 1538097[25].
- vedolizumab's World Health Organisation international non-proprietary name numeric ID is recorded as 9093[26].
- vedolizumab's pregnancy category is recorded as US pregnancy category B[27].
Why It Matters
vedolizumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (190 views/month).[2] vedolizumab has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[28] vedolizumab is known by 3 alternative names across languages and contexts.[29]